NCT06014060View on ClinicalTrials.gov

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

NARecruitingINTERVENTIONAL
Enrollment

3,300

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Elevated Lipoprotein(a) LevelCoronary Artery DiseaseDrug-Eluting StentDual Antiplatelet Therapy
Interventions
PROCEDURE

24 Months DAPT

All subjects will receive co-administration of aspirin (100 mg/day) and clopidogrel (75 mg/day) for 12 months after randomization. The DAPT will last for 24 months after PCI.

PROCEDURE

12 Months DAPT

All the subjects will receive aspirin (100 mg/day) + a placebo that is exactly the same in size, color, smell, taste and appearance as clopidogrel for 12 months after randomization. The DAPT will last for 12 months after PCI.

Trial Locations (1)

100037

RECRUITING

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV